Searched for
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...- Telangana bets big on drug discovery hubTelangana is gearing up to elevate Hyderabad's pharmaceutical standing beyond manufacturing. The state is fostering an integrated ecosystem...
- India initiates anti-dumping probes against five products from China, other nationsThe five items are moulded soda-lime glass vials; electric tractors in 6x4 and 4x2 axle configuration in any form; cyanuric chloride; polye...
- M3M Group to invest Rs 10,000 cr on construction, land acquisition in FY27
- Homegrown AlphaGrep takes on Jio BlackRock with India Algo FundsOver the next 18 months, AlphaGrep Investment Management Pvt plans to unveil about half a dozen mutual funds, Chief Executive Officer Bhaut...
- Four Indian Americans named to Carnegie's Great Immigrants list for 2026Four prominent Indian Americans, including cybersecurity leader Nikesh Arora and Harvard professor Mahzarin Banaji, have been honored by th...
- PB Fintech to inject Rs 20 crore into payments arm, expand Dubai presenceThe capital infusion will be made in one or more tranches through equity subscription and is aimed at supporting PB Pay's business expansio...
- Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
- Bombay High Court grants relief to Vadilal Mumbai branch in dispute over brand rightsThe Bombay High Court has granted interim protection to the Mumbai branch of Vadilal ice cream, recognizing its long-standing rights to the...
- KEC International shares climb 7% on Rs 1,754 crore order winKEC International shares rose nearly 7% on Tuesday after the infrastructure EPC firm announced fresh orders worth Rs 1,754 crore across its...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- ED questions CMRL Joint MD again in CMRL-Exalogic money laundering probeThe Enforcement Directorate (ED) has questioned Sharan S Kartha, Joint Managing Director of CMRL, for the second time in a money laundering...
- Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Fidelity Investments buys 2 pc stake in Lodha Developers for Rs 1,864 croreFidelity Investments has strategically acquired a 2% stake in Lodha Developers, amounting to Rs 1,864 crore, through open market operations...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India launches anti-dumping probe into electrical steel imports from China, 3 other nationsIndia has launched an anti-dumping investigation into electrical steel imports from China, Japan, Korea, and Russia. This move, prompted by...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
Load More
